Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline

McGill, Janet B. B.; Agarwal, Rajiv; Anker, Stefan D. D.; Bakris, George L. L.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M. M.; Birkenfeld, Andreas L. L.; Caramori, Maria L. L.; Brinker, Meike; Joseph, Amer; Lage, Andrea; Lawatscheck, Robert; Scott, Charlie; Rossing, Peter; FIDELIO-DKD Investigator; FIGARO-DKD Investigator

dc.contributor.author	Birkenfeld, Andreas L.
dc.date.accessioned	2023-09-22T06:14:21Z
dc.date.available	2023-09-22T06:14:21Z
dc.date.issued	2023
dc.identifier.issn	1462-8902
dc.identifier.uri	http://hdl.handle.net/10900/145875
dc.language.iso	en	en
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/dom.14999
dc.subject.ddc	610	de_DE
dc.title	Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230619000000_01030
utue.publikation.seiten	1512-1522	de_DE
utue.personen.roh	McGill, Janet B. B.
utue.personen.roh	Agarwal, Rajiv
utue.personen.roh	Anker, Stefan D. D.
utue.personen.roh	Bakris, George L. L.
utue.personen.roh	Filippatos, Gerasimos
utue.personen.roh	Pitt, Bertram
utue.personen.roh	Ruilope, Luis M. M.
utue.personen.roh	Birkenfeld, Andreas L. L.
utue.personen.roh	Caramori, Maria L. L.
utue.personen.roh	Brinker, Meike
utue.personen.roh	Joseph, Amer
utue.personen.roh	Lage, Andrea
utue.personen.roh	Lawatscheck, Robert
utue.personen.roh	Scott, Charlie
utue.personen.roh	Rossing, Peter
utue.personen.roh	FIDELIO-DKD Investigator
utue.personen.roh	FIGARO-DKD Investigator
dcterms.isPartOf.ZSTitelID	Diabetes Obesity & Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	25	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	Sonstige